JFPS - 2011年中國(guó)醫(yī)藥創(chuàng)新發(fā)展大會(huì)將在上海舉辦

全體大會(huì)

•  在中國(guó)開(kāi)展新藥研發(fā)的機(jī)遇和挑戰(zhàn)
•  跨國(guó)藥企新藥研發(fā)策略分析
•  如何在新興制藥市場(chǎng)獲得成功
•  政府在十二五期間對(duì)于醫(yī)藥行業(yè)的推動(dòng)和投資

新藥研發(fā)

藥物臨床前和臨床開(kāi)發(fā)

· 國(guó)外新藥研發(fā)進(jìn)展
· 中國(guó)重大新藥創(chuàng)制專項(xiàng)
· 傳統(tǒng)中藥
· 老藥新用
· 小組討論

· 藥物及其代謝的定量分析
· 臨床藥理學(xué)
· 臨床試驗(yàn)設(shè)計(jì)
· 與 CRO 的合作
· 小組討論

創(chuàng)新療法

藥物臨床前和臨床開(kāi)發(fā)

· 腫瘤治療
· 治療蛋白
· 治療性抗體藥物
· 人類 RNAi 治療
· 基因療法及干細(xì)胞療法

· 臨床數(shù)據(jù)管理
· 轉(zhuǎn)化醫(yī)學(xué)和生物標(biāo)記物
· 多中心臨床試驗(yàn)
· 個(gè)性化藥物中的生物信息學(xué)
· 小組討論

全體大會(huì)

•  FIPNet 模式——通向成功的制勝之寶
•  藥企研發(fā)外包及創(chuàng)新合作模式
•  臨床外包——有效管理加速產(chǎn)品上市時(shí)間
•  藥品專利過(guò)期的機(jī)遇和挑戰(zhàn)及知識(shí)產(chǎn)權(quán)戰(zhàn)略

Keynote Plenary Session

•  Challenges & Opportunities for drug innovation in China
•  MNC’s strategies for new drug R&D
•  Key factors to be successful in emerging pharmaceutical industry
•  Chinese government’s initiatives and investments in the 12 th 5-year plan

New Drug Research & Development

Preclinical & Clinical Development

· Novel drug abroad
· Key New Drug Creation and Development Program
· TCM
· New uses of old drug
· Panel Discussion

· DMPK & ADME
· Clinical pharmacology
· DOE
· CRO Corporation
· Panel Discussion

Novel Therapeutics

Preclinical & Clinical Development

· Oncology therapy
· Therapeutic proteins
· Antibody-based therapy
· Human RNAi therapy
· Gene Therapy and Stem Cell

· Data management
· Translational medicine & biomarkers
· Multicenter clinical trial
· Clinical Bioinformatics in individualized Medicine
· Panel Discussion

Plenary Session

•  Lead the way with the winning strategies, FIPNet
•  R&D outsourcing strategies and innovative partnering models
•  Driving clinical outsourcing to speed time to market through effective relationship management
•  Drug patent cliff and the evolution of IP valuation